Crossref journal-article
American Association for Cancer Research (AACR)
Cancer Epidemiology, Biomarkers & Prevention (1086)
Abstract

Abstract New Zealand Maori, Pacific, and Asian people develop melanoma less frequently than New Zealand Europeans, but little is known about melanomas that develop in these people. We examined the characteristics of melanoma in these minority ethnic groups in New Zealand. In 2007, all first primary melanomas diagnosed from January 1996 to December 2006 were extracted from the New Zealand Cancer Registry database. Melanoma was more commonly diagnosed in Maori than Asian or Pacific peoples. Age-adjusted incidence rates increased annually from 1996 to 2006 by 0.37 per 100,000 in the total population and 0.20 per 100,000 in Maori, a 12% (from 30.9 to 34.6) and 90% (from 2.3 to 4.3) increase, respectively, over the 11 years. Nodular melanoma occurred more often in Maori (15.9%) and Pacific peoples (17.1%) compared with Asians (8.7%) and New Zealand Europeans (10.5%). In Pacific peoples, acral lentiginous melanoma (22.9%) was the most common subtype. The median thickness of melanoma was 0.78 mm in New Zealand Europeans, 1.2 mm in Maori, 2.5 mm in Pacific peoples, and 0.73 mm in Asians (P < 0.001, difference in medians). Thirty-seven percent of melanomas in Pacific peoples were >4 mm thick compared with 7.9% in New Zealand Europeans. About 13% of Asians and 11% of Pacific peoples, compared with 4% of New Zealand Europeans with melanoma, were diagnosed by histology of metastases rather than the primary lesion. Minority ethnicities in New Zealand have a higher than expected risk of thick and more advanced melanoma, with poorer prognosis. Melanoma campaigns should include messages that incorporate the unique features of melanoma in minorities. (Cancer Epidemiol Biomarkers Prev 2009;18(6):1706–13)

Bibliography

Sneyd, M. J., & Cox, B. (2009). Melanoma in Maori, Asian, and Pacific Peoples in New Zealand. Cancer Epidemiology, Biomarkers & Prevention, 18(6), 1706–1713.

Authors 2
  1. Mary Jane Sneyd (first)
  2. Brian Cox (additional)
References 38 Referenced 25
  1. Statistics New Zealand. QuickStats about New Zealand: cultural diversity [cited 2008 May]. Available from: http://www.stats.govt.nz/census/census-outputs/quickstats/snapshotplace2.htm?id=9999999&tab=CulturalDiversity&type=region&ParentID=.
  2. New Zealand Health Information Services. Cancer: new registrations and deaths, 1996. Wellington (New Zealand): Ministry of Health; 2000.
  3. Gloster H, Neal K. Skin cancer in skin of color. J Am Acad Dermatol 2006;55:741–60. (10.1016/j.jaad.2005.08.063)
  4. New Zealand Health Information Service. Cancer: new registrations and deaths 2004. Wellington (New Zealand): Ministry of Health; 2007.
  5. New Zealand Health Information Service. Guide to NZHIS national collections: New Zealand Cancer Registry [cited 2008 May]. Available from: http://www.nzhis.govt.nz/moh.nsf/pagesns/64.
  6. New Zealand Health Information Service. Ethnicity data protocols for the health and disability sector [cited 2008 May]. Available from: http://www.nzhis.govt.nz/moh.nsf/pagesns/228.
  7. Statistics New Zealand. Statistical standard for ethnicity, 2005. Wellington (New Zealand): Statistics New Zealand; 2005.
  8. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970;172:902–8. (10.1097/00000658-197011000-00017)
  9. Balch C, Soong S-J, Gershenwald J, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001;19:3622–34.
  10. SEER. Summary staging [cited 2008 May]. Available from: http://training.seer.cancer.gov/module_staging_cancer/unit03_sec01_part00_sum_staging.html.
  11. StataCorp. Stata statistical software: release 10. College Station (TX): StataCorp LP, 2007.
  12. Cormier J, Xing Y, Ding M, et al. Ethnic differences among patients with cutaneous melanoma. Arch Intern Med 2006;166:1907–14. (10.1001/archinte.166.17.1907)
  13. Cress R, Holly E. Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians and blacks: an analysis of California cancer registry data. Cancer Causes Control 1997;8:246–52.
  14. Surveillance Epidemiology and End Results. Fast stats [cited 2008 May]. Available from: http://seer.cancer.gov/faststats/.
  15. Cockburn M, Zadnick J, Deapen D. Developing epidemic of melanoma in the Hispanic population of California. Cancer 2006;106:1162–8. (10.1002/cncr.21654)
  16. Swan M, Hudson D. Malignant melanoma in South Africans of mixed ancestry: a retrospective analysis. Melanoma Res 2003;13:415–9. (10.1097/00008390-200308000-00012)
  17. Ishihara K, Saida T, Yamamoto A. Updated statistical data for malignant melanoma in Japan. Int J Clin Oncol 2001;6:. (10.1007/PL00012091)
  18. Stalkup J, Orengo I, Katta R. Controversies in acral lentiginous melanoma. Dermatol Surg 2002;28:1051–9. (10.1046/j.1524-4725.2002.02082.x)
  19. Stevens N, Liff J, Weiss N. Plantar melanoma: is the incidence of melanoma of the sole of the foot really higher in blacks than whites? Int J Cancer 1990;45:691–3. (10.1002/ijc.2910450421)
  20. Cascinelli N, Zurrida S, Galimberti V, et al. Acral lentiginous melanoma: a histological type without prognostic significance. J Dermatol Surg Oncol 1994;20:817–22. (10.1111/j.1524-4725.1994.tb03711.x)
  21. Bellows C, Belafsky P, Fortgang I, Beech D. Melanoma in African-Americans: trends in biological behavior and clinical characteristics over two decades. J Surg Oncol 2001;78:10–6. (10.1002/jso.1116)
  22. Hemmings D, Johnson D, Tominaga G, Wong J. Cutaneous melanoma in a multiethnic population. Arch Surg 2004;139:968–73. (10.1001/archsurg.139.9.968)
  23. Hu S, Soza-Vento R, Parker D, Kirsner R. Comparison of stage at diagnosis of melanoma among Hispanic, black, and white patients in Miami-Dade County, Florida. Arch Dermatol 2006;142:704–8. (10.1001/archderm.142.6.704)
  24. Yamaguchi Y, Beer J, Hearing V. Melanin mediated apoptosis of epidermal cells damaged by ultraviolet radiation: factors influencing the incidence of skin cancer. Arch Dermatol Res 2008;300:Suppl 43–S50. (10.1007/s00403-007-0807-0)
  25. Hu S, Ma F, Collado-Mesa F, Kirsner R. UV radiation, latitude, and melanoma in US Hispanics and blacks. Arch Dermatol 2004;140:819–24. (10.1001/archderm.140.7.819)
  26. Eide M, Weinstock M. Association of UV index, latitude, and melanoma incidence in non-white populations: US Surveillance, Epidemiology, and End Results (SEER) program, 1992 to 2001. Arch Dermatol 2005;141:477–81. (10.1001/archderm.141.4.477)
  27. Pennello G, Devesa S, Gail M. Association of surface ultraviolet B radiation levels with melanoma and nonmelanoma skin cancer in United States blacks. Cancer Epidemiol Biomarkers Prev 2000;9:291–7.
  28. Callister P, Didham R, Potter D, Blakely T. Measuring ethnicity in New Zealand: developing tools for health outcomes analysis. Ethn Health 2007;12:299–320. (10.1080/13557850701300699)
  29. Reeder A. Results from the Maori respondents included in the national survey of awareness, understanding and response to sun protection messages in media weather reports. Dunedin (New Zealand): Social and Behavioural Research in Cancer Group, Otago University; 2001.
  30. Statistics New Zealand. QuickStats about New Zealand's population and dwellings. 2006 census. Available from: http://www.stats.govt.nz/census/2006-census-data/quickstats-about-nzs-pop-and-dwellings/quickstats-about-nzs-pop-and-dwellings-revised.htm?page=para007Master.
  31. Fitzpatrick T. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988;124:869–71. (10.1001/archderm.124.6.869)
  32. Parra E, Kittles R, Shriver M. Implications of correlations between skin color and genetic ancestry for biomedical research. Nature Genetics 2004;36:Suppl 54–60. (10.1038/ng1440)
  33. Youn J, Oh J, Kim B, et al. Relationship between skin phototype and MED in Korean, brown skin. Photodermatol Photoimmunol Photomed 1997;13:208–11. (10.1111/j.1600-0781.1997.tb00233.x)
  34. Statistics New Zealand. Change in ethnicity question—2001 census of population and dwellings. 2008. Wellington: Statistics New Zealand; 2007.
  35. Miller D, Geller A, Koh H. Survey of knowledge of and awareness about melanoma—United States, 1995. MMWR Morb Mortal Wkly Rep 1996;45:346–9.
  36. Pipitone M, Robinson J, Camara C, Chittineni B, Fisher S. Skin cancer awareness in suburban employees: a Hispanic perspective. J Am Acad Dermatol 2002;47:118–23. (10.1067/mjd.2002.120450)
  37. Wright C, Reeder A, Gray A, Cox B. UVR exposure of NZ schoolchildren. Dunedin (New Zealand): University of Otago; 2007.
  38. Baumert J, Plewig G, Volkenandt M, Schmid-Wendtner M-H. Factors associated with a high tumour thickness in patients with melanoma. Br J Dermatol 2007;156:938–44. (10.1111/j.1365-2133.2007.07805.x)
Dates
Type When
Created 16 years, 2 months ago (June 8, 2009, 3:27 a.m.)
Deposited 3 years, 2 months ago (June 9, 2022, 5:58 p.m.)
Indexed 4 days, 13 hours ago (Sept. 3, 2025, 5:59 a.m.)
Issued 16 years, 3 months ago (June 1, 2009)
Published 16 years, 3 months ago (June 1, 2009)
Published Online 16 years, 2 months ago (June 8, 2009)
Published Print 16 years, 3 months ago (June 1, 2009)
Funders 0

None

@article{Sneyd_2009, title={Melanoma in Maori, Asian, and Pacific Peoples in New Zealand}, volume={18}, ISSN={1538-7755}, url={http://dx.doi.org/10.1158/1055-9965.epi-08-0682}, DOI={10.1158/1055-9965.epi-08-0682}, number={6}, journal={Cancer Epidemiology, Biomarkers & Prevention}, publisher={American Association for Cancer Research (AACR)}, author={Sneyd, Mary Jane and Cox, Brian}, year={2009}, month=jun, pages={1706–1713} }